Prosecution Insights
Last updated: May 29, 2026
Application No. 35/520,373

Instrument for manipulating reagent droplets

Non-Final OA §112
Filed
Feb 08, 2024
Priority
Aug 14, 2023 — GB 6303458
Examiner
GROSS, KELLY L
Art Unit
2943
Tech Center
2900
Assignee
Nuclera Ltd.
OA Round
1 (Non-Final)
96%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 96% — above average
96%
Career Allowance Rate
212 granted / 221 resolved
+35.9% vs TC avg
Minimal +1% lift
Without
With
+1.1%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 0m
Avg Prosecution
2 currently pending
Career history
223
Total Applications
across all art units

Statute-Specific Performance

§103
2.6%
-37.4% vs TC avg
§102
4.4%
-35.6% vs TC avg
§112
90.4%
+50.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 221 resolved cases

Office Action

§112
Detailed Action Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Objection to the Specification It is suggested that the design description be amended to address all views and should read as follows: --- 1.1 Perspective 1.2 Front 1.3 Right side 1.4 Back 1.5 Left side 1.6 Top 1.7 Bottom --- Claim Rejections - 35 USC § 112 The claim is rejected under 35 U.S.C. 112(a) and (b) or pre-AIA 35 U.S.C. 112, first and second paragraphs, as the claimed invention is not described in such full, clear, concise, and exact terms as to enable any person skilled in the art to make and use the same, and fails to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or, for applications subject to pre-AIA 35 U.S.C. 112, the applicant) regards as the invention. The claim is indefinite and nonenabling because the shape and appearance of some portions of the design are unclear due to inconsistent and insufficient disclosure of the claimed design. Specifically, the following are noted: PNG media_image1.png 754 1430 media_image1.png Greyscale The full depth and shape of some of the solid line features seen in Figures 1.1, 1.3, 1.4 and 1.7 cannot be confirmed based on the views provided. Similarly, many of the smaller solid line details cannot be understood due to the bleeding together of features. Please see below: PNG media_image2.png 717 1429 media_image2.png Greyscale Applicant may indicate that protection is not sought for those portions of the reproductions which are considered indefinite and nonenabling in the rejection under 35 U.S.C. 112 above by amending the reproductions to color those portions or convert those portions to broken lines and by amending the specification to include a statement that the portions of the instrument for manipulating reagent droplets shown in broken lines form no part of the claimed design or a statement that the portions of the instrument for manipulating reagent droplets shown by coloring form no part of the claimed design, provided such amendments do not introduce new matter (see 35 U.S.C. 132, 37 CFR 1.121). When preparing new or replacement reproductions, be careful to avoid introducing new matter. New matter is prohibited by 35 U.S.C. 132 and 37 CFR 1.121(f). Corrected reproduction sheets are required in reply to the Office action to avoid abandonment of the application. Any amended replacement reproduction sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended reproduction should not be labeled as “amended.” If a reproduction figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the reproductions for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. If all the figures on a reproduction sheet are canceled, a replacement sheet is not required. A marked-up copy of the reproduction sheet (labeled as “Annotated Sheet”) including an annotation showing that all the figures on that reproduction sheet have been canceled must be presented in the amendment or remarks section that explains the change to the reproductions. Each reproduction sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. Summation The claim stands rejected for the reasons set forth above. The references cited but not applied, are considered cumulative art related to the claimed design. Reply Reminder Applicant is reminded that any reply to this communication must be signed either by a patent practitioner (i.e., a patent attorney or agent registered to practice before the United States Patent and Trademark Office) or by the applicant. If the applicant is a juristic entity, the reply must be signed by a patent practitioner. See 37 CFR 1.33(b). Discussion of the Merits of the Application All discussions between the applicant and the examiner regarding the merits of a pending application will be considered an interview and are to be made of record. See MPEP 713. The examiner will not discuss the merits of the application with applicant’s representative if the representative is not registered to practice before the USPTO. Appointment as applicant’s representative before the International Bureau pursuant to Rule 3 of the Common Regulations under the Hague Agreement does NOT entitle such representative to represent the applicant before the USPTO. Furthermore, an applicant that is a juristic entity must be represented by a patent attorney or agent registered to practice before the USPTO. Additional information regarding interviews is set forth below. Telephonic or in person interviews A telephonic or in person interview may only be conducted with an attorney or agent registered to practice before the USPTO (“registered practitioner”) or with a pro se applicant (an applicant who is the inventor and who is not represented by a registered practitioner). The registered practitioner may either be of record or not of record. To become “of record”, a power of attorney (POA) in accordance with 37 CFR 1.32 must be filed in the application. Form PTO/AIA /80 “Power of Attorney to Prosecute Applications Before the USPTO”, available at https://www.uspto.gov/patent/forms/forms-patent-applications-filed-or-after-september-16-2012, may be used for this purpose. See MPEP 402.02(a) for further information. Interviews may also be conducted with a registered practitioner not of record provided the registered practitioner can show authorization to conduct an interview by completing, signing and filing an “Applicant Initiated Interview Request Form” (PTOL-413A) (available at the USPTO web page indicated above). See MPEP 405. For acceptable ways to submit forms to the USPTO, see “When Responding to Official USPTO Correspondence” below. Responding to Official USPTO Correspondence The USPTO transacts business in writing. All replies must be signed in accordance with 37 CFR 1.33(b). Pursuant to 37 CFR 1.33(b)(3), a reply submitted on behalf of a juristic applicant must be signed by an attorney or agent registered to practice before the USPTO. Applicants may submit replies to Office actions only by:  Online via the USPTO's Electronic Filing System‐Web (EFS‐Web) (Registered eFilers only) https://www.uspto.gov/patents/apply  Mail: Commissioner for Patents, P.O. Box 1450, Alexandria, VA, 22313‐1450  Facsimile to the USPTO's Official Fax Number (571‐273‐8300)  Hand‐carry to USPTO's Alexandria, Virginia Customer Service Window https://www.uspto.gov/patents/maintain/responding-office-actions Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KELLY L GROSS whose telephone number is (571)272-9063. The examiner can normally be reached Monday-Friday, 9 a.m. - 5 p.m.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sandra Snapp can be reached on (571) 272-8364. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KELLY L GROSS/Examiner, Art Unit 2912 /T Chase NELSON/Primary Examiner, Art Unit 2926
Read full office action

Prosecution Timeline

Feb 08, 2024
Application Filed
Dec 05, 2024
Non-Final Rejection mailed — §112
Feb 25, 2025
Response Filed
Jul 16, 2025
Examiner Interview Summary
Jul 22, 2025
Response after Non-Final Action
Jul 22, 2025
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent D1125590
Fixed apparatus and equipment for laboratories
2y 8m to grant Granted May 05, 2026
Patent D1123186
Laboratory table
1y 2m to grant Granted Apr 21, 2026
Patent D1116115
Medical endoscopic image processor
1y 3m to grant Granted Mar 03, 2026
Patent D1105428
X-RAY TUBE
4y 8m to grant Granted Dec 09, 2025
Patent D1104264
CONTROL ELECTRODE FOR AN X-RAY TUBE CATHODE
3y 11m to grant Granted Dec 02, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
96%
Grant Probability
97%
With Interview (+1.1%)
2y 0m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 221 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month